/**
 * Script to add new banned substances to the database
 */

const fs = require('fs');
const path = require('path');

const dataPath = path.join(__dirname, '..', 'lib', 'data', 'banned-substances.json');

// Read existing data
const data = JSON.parse(fs.readFileSync(dataPath, 'utf-8'));

// New substances to add
const newSubstances = [
  {
    "id": "banned-dmha",
    "slug": "dmha",
    "name": "DMHA (Octodrine)",
    "alternativeNames": ["2-Aminoisoheptane", "Octodrine", "2-amino-6-methylheptane", "1,5-Dimethylhexylamine"],
    "category": "stimulant",
    "legalStatus": "banned_usa",
    "legalStatusDetails": "FDA issued 12 warning letters in April 2019. Products containing DMHA are adulterated.",
    "bannedBy": ["FDA", "WADA"],
    "stateRestrictions": {"US": "FDA Warning Letters", "Australia": "Banned"},
    "healthRisks": [{"category": "Cardiovascular", "description": "Supplements contained 72±7.5 mg per serving, more than twice historical pharmaceutical doses. Causes hypertension, tachycardia, hyperthermia.", "severity": "high", "sources": ["FDA Warning Letters 2019"]}],
    "sideEffects": ["Hypertension", "Tachycardia", "Hyperthermia", "Anxiety", "Jitters", "Insomnia"],
    "contraindications": ["Heart conditions", "High blood pressure", "Anxiety disorders", "Stimulant sensitivity"],
    "overdoseRisk": "high",
    "addictionPotential": "moderate",
    "description": "DMHA (2-aminoisoheptane) is a synthetic stimulant originally developed in the 1950s as an inhaled nasal decongestant—never approved for oral use. It emerged as a DMAA alternative in pre-workout supplements after the 2013 DMAA ban.",
    "mechanism": "Sympathomimetic amine that stimulates norepinephrine release, causing increased heart rate, blood pressure, and thermogenesis.",
    "history": "Originally patented in the 1950s as a nasal decongestant. Resurfaced in supplements around 2016 as 'DMAA alternative'. FDA cracked down in 2019 with 12 warning letters to companies including Hi-Tech Pharmaceuticals.",
    "whyBanned": "FDA determined DMHA is an unsafe food additive. Never tested for oral human use at supplement doses. Products are adulterated under DSHEA.",
    "legalAlternatives": ["caffeine", "citrulline-malate", "beta-alanine"],
    "metaTitle": "DMHA (Octodrine) - FDA Banned Stimulant & Safe Alternatives",
    "metaDescription": "Learn why DMHA (2-aminoisoheptane, Octodrine) was banned by FDA in 2019, its dangerous cardiovascular effects, and discover safe legal pre-workout alternatives.",
    "keywords": ["dmha", "octodrine", "2-aminoisoheptane", "dmha pre workout", "dmha banned", "dmha alternative", "dmha side effects", "dmha dangers"],
    "createdAt": "2025-01-27T00:00:00Z",
    "updatedAt": "2025-01-27T00:00:00Z"
  },
  {
    "id": "banned-bmpea",
    "slug": "bmpea",
    "name": "BMPEA",
    "alternativeNames": ["β-methylphenylethylamine", "Beta-methylphenethylamine", "2-Phenylpropan-1-amine"],
    "category": "stimulant",
    "legalStatus": "banned_usa",
    "legalStatusDetails": "FDA issued 5 warning letters in April 2015. BMPEA is a synthetic adulterant, NOT naturally present in Acacia rigidula despite label claims.",
    "bannedBy": ["FDA"],
    "stateRestrictions": {"US": "FDA Warning Letters 2015"},
    "healthRisks": [{"category": "Cardiovascular", "description": "Swedish case report documented cerebral hemorrhage in female athlete after consuming supplement with 290 mg BMPEA (unlabeled).", "severity": "high", "sources": ["FDA Research 2013", "Swedish Medical Case Report"]}],
    "sideEffects": ["Cerebral hemorrhage", "Hypertension", "Tachycardia", "Anxiety", "Palpitations", "Stroke"],
    "contraindications": ["Heart conditions", "Stroke history", "High blood pressure", "Use of other stimulants"],
    "overdoseRisk": "high",
    "addictionPotential": "moderate",
    "description": "BMPEA (β-methylphenylethylamine) is a positional isomer of amphetamine. FDA research in 2013 established it is NOT naturally present in Acacia rigidula—despite label claims, it is a synthetic adulterant with approximately 1/10th amphetamine potency.",
    "mechanism": "Substrate-type releaser at norepinephrine transporters. Structural isomer of amphetamine with similar but less potent stimulant effects on the central nervous system.",
    "history": "Marketed as 'natural' Acacia rigidula extract in numerous supplements. FDA scientifically proved it was a synthetic adulterant in 2013. Warning letters issued to 5 companies in April 2015.",
    "whyBanned": "Synthetic stimulant fraudulently labeled as natural plant extract. Never approved for human consumption. Amphetamine-like cardiovascular effects.",
    "legalAlternatives": ["caffeine", "l-tyrosine"],
    "metaTitle": "BMPEA - Amphetamine Analog Banned by FDA & Safe Alternatives",
    "metaDescription": "BMPEA is an amphetamine isomer found as synthetic adulterant in 'Acacia rigidula' supplements. Learn why FDA banned it and find safe legal alternatives.",
    "keywords": ["bmpea", "beta-methylphenethylamine", "acacia rigidula", "bmpea supplement", "bmpea banned", "bmpea dangers", "bmpea amphetamine"],
    "createdAt": "2025-01-27T00:00:00Z",
    "updatedAt": "2025-01-27T00:00:00Z"
  },
  {
    "id": "banned-tianeptine",
    "slug": "tianeptine",
    "name": "Tianeptine",
    "alternativeNames": ["Zaza", "Tianaa", "Neptune's Fix", "Gas Station Heroin", "Stablon", "Coaxil", "TD Red", "Zaza Red"],
    "category": "other",
    "legalStatus": "restricted",
    "legalStatusDetails": "Scheduled in 12+ states including Alabama (Schedule I), Florida (Schedule I), Michigan (Schedule II), Ohio (Schedule I). FDA consumer warnings issued 2022-2025.",
    "bannedBy": ["FDA (warnings)", "Multiple states"],
    "stateRestrictions": {"Alabama": "Schedule I", "Florida": "Schedule I", "Michigan": "Schedule II", "Ohio": "Schedule I", "Tennessee": "Schedule II", "Indiana": "Controlled", "Kentucky": "Controlled", "Georgia": "Controlled", "Mississippi": "Controlled"},
    "healthRisks": [{"category": "Opioid Toxicity", "description": "CDC documented poison center calls increasing from 11 total (2000-2013) to 391 in 2023. Effects mimic opioid toxicity and withdrawal. Users ingesting 1.3 to 250 times typical pharmaceutical doses.", "severity": "high", "sources": ["CDC MMWR August 2018", "CDC 2023 Report", "DEA Reports"]}],
    "sideEffects": ["Opioid-like euphoria", "Respiratory depression", "Severe withdrawal syndrome", "Seizures", "Coma", "Death", "Nausea", "Constipation"],
    "contraindications": ["Opioid use disorder", "CNS depressant use", "Respiratory conditions", "Pregnancy", "Alcohol use"],
    "overdoseRisk": "high",
    "addictionPotential": "high",
    "description": "Tianeptine is an atypical tricyclic antidepressant that acts as a mu-opioid receptor agonist. Known as 'gas station heroin' due to its availability at convenience stores and gas stations, and its severe opioid-like effects at high doses. Commonly sold as Zaza, Tianaa, Neptune's Fix, and TD Red.",
    "mechanism": "Mu-opioid receptor agonist causing euphoria and analgesia similar to traditional opioids. At high doses (commonly seen in abuse), produces full opioid toxicity including respiratory depression and severe physical dependence with life-threatening withdrawal.",
    "history": "Prescription drug in Europe, Asia, and Latin America since the 1980s for depression. Never FDA approved. Emerged in US as 'dietary supplement' around 2010. Multiple states scheduled after documented deaths and an addiction epidemic. Known as 'gas station heroin' crisis.",
    "whyBanned": "Opioid-like effects causing severe addiction, overdose, and death. Products sold at doses up to 250 times therapeutic levels. 'Gas station heroin' epidemic with opioid withdrawal syndrome.",
    "legalAlternatives": ["l-theanine", "ashwagandha", "rhodiola-rosea", "magnesium-glycinate"],
    "metaTitle": "Tianeptine (Zaza, Gas Station Heroin) - Dangers, Deaths & Safer Alternatives",
    "metaDescription": "Tianeptine (Zaza, Tianaa, Neptune's Fix) is 'gas station heroin' causing severe opioid addiction and deaths. Learn the dangers, withdrawal symptoms, and find safe legal alternatives.",
    "keywords": ["tianeptine", "zaza", "tianaa", "neptunes fix", "gas station heroin", "tianeptine withdrawal", "tianeptine addiction", "tianeptine banned", "tianeptine deaths", "zaza red", "td red"],
    "createdAt": "2025-01-27T00:00:00Z",
    "updatedAt": "2025-01-27T00:00:00Z"
  },
  {
    "id": "banned-adrafinil",
    "slug": "adrafinil",
    "name": "Adrafinil",
    "alternativeNames": ["CRL-40028", "Olmifon"],
    "category": "nootropic",
    "legalStatus": "banned_usa",
    "legalStatusDetails": "FDA classified as unapproved new drug. Criminal prosecutions with prison sentences for sellers. In 2023, Nootropics Depot CEO was sentenced to prison and ordered to forfeit $2.4 million.",
    "bannedBy": ["FDA", "WADA"],
    "stateRestrictions": {"US": "Unapproved Drug - Criminal Prosecution Active"},
    "healthRisks": [{"category": "Hepatotoxicity", "description": "Liver enzyme elevations with prolonged use. The prodrug form was voluntarily discontinued in France in 2011 due to 'unfavorable risk-benefit ratio' from liver concerns.", "severity": "moderate", "sources": ["French Health Authority 2011", "Clinical Reports"]}, {"category": "Legal", "description": "2023: Nootropics Depot CEO sentenced to prison, $2.4 million forfeiture for selling adrafinil, tianeptine, and phenibut.", "severity": "high", "sources": ["DOJ Press Release 2023"]}],
    "sideEffects": ["Liver toxicity", "Elevated liver enzymes", "Insomnia", "Anxiety", "Headache", "Nausea", "Skin reactions"],
    "contraindications": ["Liver disease", "Heart conditions", "Seizure disorders", "Pregnancy", "Other hepatotoxic drugs"],
    "overdoseRisk": "moderate",
    "addictionPotential": "low",
    "description": "Adrafinil is a prodrug of modafinil, a DEA Schedule IV controlled substance. It requires hepatic metabolism to produce the active drug, placing significant strain on the liver. Selling adrafinil has resulted in criminal prosecution and prison time for supplement sellers.",
    "mechanism": "Metabolized by the liver into modafinil (Schedule IV). Increases dopamine and norepinephrine neurotransmission, promoting wakefulness. Hepatotoxic due to extensive first-pass metabolism required for activation.",
    "history": "Developed in France in the 1970s by Lafon Laboratories for narcolepsy treatment. Voluntarily discontinued in France in 2011 due to liver risks and availability of modafinil. US supplement sellers prosecuted criminally in 2023.",
    "whyBanned": "Prodrug of DEA Schedule IV controlled substance (modafinil). Classified as unapproved new drug by FDA. Hepatotoxic. Active criminal enforcement with prison sentences.",
    "legalAlternatives": ["caffeine", "l-theanine", "alpha-gpc", "lions-mane"],
    "metaTitle": "Adrafinil - Modafinil Prodrug, Liver Damage, Prison Sentences & Safe Alternatives",
    "metaDescription": "Adrafinil is a prodrug of modafinil that causes liver damage. Learn why sellers are going to prison and find safe legal nootropic alternatives for focus and wakefulness.",
    "keywords": ["adrafinil", "olmifon", "adrafinil liver", "adrafinil modafinil", "adrafinil legal", "adrafinil banned", "adrafinil alternative", "adrafinil side effects", "adrafinil hepatotoxicity"],
    "createdAt": "2025-01-27T00:00:00Z",
    "updatedAt": "2025-01-27T00:00:00Z"
  },
  {
    "id": "banned-phenylpiracetam",
    "slug": "phenylpiracetam",
    "name": "Phenylpiracetam",
    "alternativeNames": ["Carphedon", "Phenotropil", "4-Phenylpiracetam", "Fonturacetam"],
    "category": "nootropic",
    "legalStatus": "banned_usa",
    "legalStatusDetails": "FDA classifies as unapproved new drug. WADA prohibited since 1998—the ONLY racetam on WADA's banned list. Named in 2022-2023 criminal enforcement actions.",
    "bannedBy": ["FDA", "WADA"],
    "stateRestrictions": {"US": "Unapproved Drug - Criminal Enforcement", "Russia": "Prescription Only (Phenotropil)"},
    "healthRisks": [{"category": "Sports/Legal", "description": "Multiple doping cases including Russian Olympic biathlete Olga Pyleva (2006 silver medal stripped). Named in 2022-2023 US criminal enforcement actions against supplement sellers.", "severity": "high", "sources": ["WADA Doping Cases", "DOJ Enforcement 2023"]}],
    "sideEffects": ["Insomnia", "Irritability", "Headache", "Overstimulation", "Anxiety", "Increased blood pressure"],
    "contraindications": ["Competitive athletes (career-ending)", "Anxiety disorders", "Insomnia", "Hypertension"],
    "overdoseRisk": "low",
    "addictionPotential": "low",
    "description": "Phenylpiracetam (Carphedon) is the ONLY racetam on WADA's prohibited list, banned in-competition since 1998. It's a prescription drug in Russia for cerebrovascular deficiency and depression. FDA classifies it as an unapproved drug in the US, and it has been named in criminal enforcement actions.",
    "mechanism": "Racetam nootropic with an added phenyl group that significantly increases potency and adds stimulant-like effects. Enhances dopamine and norepinephrine activity beyond other racetams.",
    "history": "Developed in Russia in 1983 for Soviet cosmonauts to combat stress and cold tolerance. Approved in Russia as prescription drug Phenotropil in 2003. Multiple Olympic doping scandals. US criminal enforcement 2022-2023.",
    "whyBanned": "Unapproved drug with significant stimulant properties. The ONLY WADA-banned racetam due to performance enhancing effects. Career-ending for competitive athletes.",
    "legalAlternatives": ["caffeine", "alpha-gpc", "lions-mane", "bacopa-monnieri"],
    "metaTitle": "Phenylpiracetam (Carphedon) - WADA Banned, Only Banned Racetam & Legal Alternatives",
    "metaDescription": "Phenylpiracetam is the ONLY racetam banned by WADA since 1998. Learn why athletes lose Olympic medals and careers, and find safe legal nootropic alternatives.",
    "keywords": ["phenylpiracetam", "carphedon", "phenotropil", "phenylpiracetam banned", "phenylpiracetam wada", "phenylpiracetam legal", "phenylpiracetam alternative", "phenylpiracetam doping"],
    "createdAt": "2025-01-27T00:00:00Z",
    "updatedAt": "2025-01-27T00:00:00Z"
  },
  {
    "id": "banned-ostarine",
    "slug": "ostarine",
    "name": "Ostarine (MK-2866)",
    "alternativeNames": ["MK-2866", "Enobosarm", "GTx-024", "S-22"],
    "category": "sarm",
    "legalStatus": "banned_usa",
    "legalStatusDetails": "Unapproved drug—cannot legally be sold as supplement or for human consumption. 20+ drug-induced liver injury cases documented in medical literature since 2020. Active criminal enforcement.",
    "bannedBy": ["FDA", "WADA", "DEA (enforcement)"],
    "stateRestrictions": {"US": "Unapproved Drug - Criminal Enforcement Active"},
    "healthRisks": [{"category": "Hepatotoxicity", "description": "Over 20 drug-induced liver injury (DILI) cases documented in NIH PubMed medical literature since 2020. Cholestatic liver injury pattern.", "severity": "high", "sources": ["NIH PubMed Case Reports", "Hepatology Journals"]}, {"category": "Hormonal", "description": "Significant testosterone suppression requiring Post-Cycle Therapy. Development discontinued after failing to improve muscle strength in cancer patient trials.", "severity": "moderate", "sources": ["GTx Clinical Trials"]}],
    "sideEffects": ["Liver injury", "Testosterone suppression", "Acne", "Hair loss", "Mood changes", "Gynecomastia", "Cholestatic jaundice"],
    "contraindications": ["Liver disease", "Hormone-sensitive conditions", "Women (virilization risk)", "Competitive athletes"],
    "overdoseRisk": "moderate",
    "addictionPotential": "moderate",
    "description": "Ostarine (MK-2866/Enobosarm) is the most commonly detected SARM in both doping tests and supplement adulteration testing. Development by GTx was discontinued after failing Phase 3 clinical trials to improve muscle strength in cancer patients. Over 20 documented liver injury cases.",
    "mechanism": "Selective Androgen Receptor Modulator that binds to androgen receptors primarily in muscle and bone tissue. Despite claimed selectivity, causes significant testosterone suppression requiring PCT.",
    "history": "Developed by GTx Inc. for cancer-related muscle wasting. Failed Phase 3 clinical trials. Most detected SARM globally with over 230 positive doping tests since 2012. Frequently found as undeclared adulterant in supplements.",
    "whyBanned": "Unapproved drug causing documented liver injury cases. Development abandoned after failing efficacy trials. Most common SARM in doping violations and supplement adulteration.",
    "legalAlternatives": ["creatine-monohydrate"],
    "metaTitle": "Ostarine (MK-2866) - Liver Injury Risk, Failed Trials & Legal Alternatives",
    "metaDescription": "Ostarine (MK-2866) causes liver damage with 20+ documented cases. Learn why this SARM failed clinical trials and find safe legal muscle-building alternatives.",
    "keywords": ["ostarine", "mk-2866", "enobosarm", "ostarine side effects", "ostarine liver", "ostarine legal", "ostarine alternative", "ostarine banned", "ostarine liver damage"],
    "createdAt": "2025-01-27T00:00:00Z",
    "updatedAt": "2025-01-27T00:00:00Z"
  },
  {
    "id": "banned-andarine",
    "slug": "andarine",
    "name": "Andarine (S-4)",
    "alternativeNames": ["S-4", "GTx-007", "Acetamidoxolutamide"],
    "category": "sarm",
    "legalStatus": "banned_usa",
    "legalStatusDetails": "Unapproved drug. Development discontinued in favor of ostarine due to unique and concerning vision side effects.",
    "bannedBy": ["FDA", "WADA"],
    "stateRestrictions": {"US": "Unapproved Drug"},
    "healthRisks": [{"category": "Vision", "description": "Unique and concerning side effect: visual disturbances including yellow-tinted vision (everything appears yellow) and significant difficulty adjusting to darkness/night blindness.", "severity": "moderate", "sources": ["User Reports", "Clinical Observations", "Pharmacology Studies"]}],
    "sideEffects": ["Yellow vision tint", "Night vision problems/blindness", "Difficulty adjusting to light changes", "Testosterone suppression", "Liver stress", "Hair loss"],
    "contraindications": ["Vision problems", "Driving at night", "Liver disease", "Hormone-sensitive conditions", "Pilots/drivers"],
    "overdoseRisk": "moderate",
    "addictionPotential": "moderate",
    "description": "Andarine (S-4) is a SARM with a unique and particularly concerning side effect: vision disturbances including yellow-tinted vision and significant difficulty adjusting to darkness. Development was discontinued in favor of ostarine due to these vision problems.",
    "mechanism": "Binds to androgen receptors in muscle tissue but ALSO binds to receptors in the eye's retina, causing the characteristic yellow vision and night blindness. Less selective than originally claimed.",
    "history": "Early SARM developed by GTx Inc. Discontinued during development due to the unexpected and concerning vision side effects. Development efforts shifted to ostarine instead.",
    "whyBanned": "Unapproved drug with unique vision impairment side effects that could endanger users (driving, operating machinery). Never completed clinical development due to safety concerns.",
    "legalAlternatives": ["creatine-monohydrate"],
    "metaTitle": "Andarine (S-4) - Yellow Vision, Night Blindness & Safer Alternatives",
    "metaDescription": "Andarine (S-4) causes yellow-tinted vision and night blindness. Learn why this SARM was abandoned and find safe legal muscle-building alternatives.",
    "keywords": ["andarine", "s-4", "andarine vision", "andarine side effects", "andarine yellow vision", "andarine night blindness", "andarine legal", "andarine alternative"],
    "createdAt": "2025-01-27T00:00:00Z",
    "updatedAt": "2025-01-27T00:00:00Z"
  },
  {
    "id": "banned-yohimbine",
    "slug": "yohimbine",
    "name": "Yohimbine/Yohimbe",
    "alternativeNames": ["Yohimbe bark", "Pausinystalia yohimbe", "Yohimbine HCl", "Quebrachine"],
    "category": "other",
    "legalStatus": "restricted",
    "legalStatusDetails": "Yohimbine HCl is an FDA-approved PRESCRIPTION drug. Yohimbe bark extract sold as supplement but with 5.81x higher serious outcome rate than average poisonings.",
    "bannedBy": ["FDA (prescription requirement for pure form)"],
    "stateRestrictions": {"US": "Yohimbine HCl = Prescription Only; Yohimbe bark = High-risk supplement"},
    "healthRisks": [{"category": "Cardiovascular", "description": "California Poison Control System study (2000-2006): 238 yohimbine cases with 5.81x higher odds of serious outcomes than average poison exposures. Documented cardiac arrhythmias, myocardial infarction, seizures, and acute renal failure.", "severity": "high", "sources": ["California Poison Control System 2000-2006", "Clinical Case Reports"]}],
    "sideEffects": ["Cardiac arrhythmias", "Hypertension", "Myocardial infarction", "Anxiety", "Panic attacks", "Seizures", "Acute renal failure", "Tremor"],
    "contraindications": ["Heart disease", "Anxiety disorders", "Hypertension", "Kidney disease", "MAO inhibitor use", "SSRI use"],
    "overdoseRisk": "high",
    "addictionPotential": "low",
    "description": "Yohimbine is an α2-adrenergic receptor antagonist from yohimbe bark. The pure compound (yohimbine HCl) is an FDA-approved prescription drug for erectile dysfunction. Bark extracts sold as supplements have highly variable yohimbine content (up to 154% variation) with inadequate safety labeling and 5.81x higher serious outcome rate.",
    "mechanism": "Blocks α2-adrenergic receptors, causing increased norepinephrine release throughout the body. Results in elevated blood pressure, heart rate, and anxiety. Also affects fat mobilization.",
    "history": "Traditional use in West Africa as aphrodisiac. Yohimbine HCl approved as prescription drug for ED. Bark supplements are poorly regulated with a 2015 analysis of 49 supplements showing highly variable and often undisclosed yohimbine content.",
    "whyBanned": "Pure yohimbine requires prescription. Bark supplements have dangerous content variability and 5.81x higher odds of serious poisoning outcomes including cardiac events and seizures.",
    "legalAlternatives": ["caffeine", "l-carnitine"],
    "metaTitle": "Yohimbine/Yohimbe - 5.81x More Dangerous, Heart Risks & Safer Alternatives",
    "metaDescription": "Yohimbine causes cardiac arrhythmias with 5.81x more serious poisonings than average. Learn the risks of yohimbe supplements and find safe legal fat loss alternatives.",
    "keywords": ["yohimbine", "yohimbe", "yohimbine side effects", "yohimbe dangers", "yohimbine heart", "yohimbe legal", "yohimbine alternative", "yohimbe bark"],
    "createdAt": "2025-01-27T00:00:00Z",
    "updatedAt": "2025-01-27T00:00:00Z"
  },
  {
    "id": "banned-higenamine",
    "slug": "higenamine",
    "name": "Higenamine",
    "alternativeNames": ["Norcoclaurine", "Demethylcoclaurine", "1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol"],
    "category": "stimulant",
    "legalStatus": "restricted",
    "legalStatusDetails": "FDA warning letters May 2022—determined to be a New Dietary Ingredient requiring premarket notification (none submitted). WADA prohibited at ALL times since 2017.",
    "bannedBy": ["FDA (NDI requirement)", "WADA"],
    "stateRestrictions": {"US": "NDI Required - Products Adulterated", "Sports": "WADA Prohibited - All Competition Times"},
    "healthRisks": [{"category": "Sports/Career", "description": "WADA prohibited since 2017 under S3 Beta-2 Agonists. Reporting threshold: 10 ng/mL in urine. Caused UEFA footballer Mamadou Sakho's suspension in 2016. Multiple athlete career-ending suspensions.", "severity": "high", "sources": ["WADA Prohibited List", "Doping Cases"]}],
    "sideEffects": ["Tachycardia", "Palpitations", "Tremor", "Anxiety", "Headache", "Arrhythmias"],
    "contraindications": ["Competitive athletes (career-ending)", "Heart conditions", "Arrhythmias", "Asthma medication use (β2 agonists)"],
    "overdoseRisk": "moderate",
    "addictionPotential": "low",
    "description": "Higenamine is a β2-adrenergic agonist found naturally in lotus seeds, Nandina domestica, aconite root, and beetroot. FDA determined it requires New Dietary Ingredient notification (none submitted). WADA banned since 2017—has ended athletic careers including UEFA footballer Mamadou Sakho.",
    "mechanism": "Activates β2-adrenergic receptors causing bronchodilation, increased heart rate, and thermogenesis. Effects similar to ephedrine and other banned β2 agonists.",
    "history": "Traditional use in Chinese medicine (lotus seeds). Emerged in pre-workout supplements around 2015. WADA added to prohibited list effective January 2017. FDA issued warning letters May 2022 for missing NDI notifications.",
    "whyBanned": "New Dietary Ingredient without required FDA premarket notification. WADA prohibited as β2-agonist at all times. Career-ending for competitive athletes in any sport.",
    "legalAlternatives": ["caffeine", "citrulline-malate", "beta-alanine"],
    "metaTitle": "Higenamine - WADA Banned, Career-Ending for Athletes & Safe Alternatives",
    "metaDescription": "Higenamine is banned by WADA and flagged by FDA. Learn why athletes lose careers over this ingredient and find safe legal pre-workout alternatives.",
    "keywords": ["higenamine", "higenamine banned", "higenamine wada", "higenamine fda", "higenamine legal", "higenamine supplement", "higenamine alternative", "higenamine doping"],
    "createdAt": "2025-01-27T00:00:00Z",
    "updatedAt": "2025-01-27T00:00:00Z"
  },
  {
    "id": "banned-vinpocetine",
    "slug": "vinpocetine",
    "name": "Vinpocetine",
    "alternativeNames": ["Ethyl apovincaminate", "Cavinton", "Intelectol"],
    "category": "nootropic",
    "legalStatus": "restricted",
    "legalStatusDetails": "FDA June 2019 critical pregnancy warning—NIH found clear evidence it causes miscarriages and fetal harm. FDA tentatively ruled vinpocetine ineligible for dietary supplement status.",
    "bannedBy": ["FDA (pregnancy warning, tentative ineligibility ruling)"],
    "stateRestrictions": {"US": "FDA Pregnancy Warning - Tentatively Ineligible for Supplements"},
    "healthRisks": [{"category": "Reproductive", "description": "NIH National Toxicology Program found clear evidence vinpocetine triggers miscarriages and causes fetal harm in animal studies at blood levels similar to humans after taking a SINGLE dose.", "severity": "high", "sources": ["NIH National Toxicology Program Study", "FDA Safety Alert June 2019"]}],
    "sideEffects": ["Miscarriage", "Fetal harm/developmental toxicity", "Headache", "Dizziness", "Nausea", "Sleep disturbances", "Facial flushing"],
    "contraindications": ["Pregnancy", "Women of childbearing age", "Women trying to conceive", "Bleeding disorders", "Surgery patients"],
    "overdoseRisk": "low",
    "addictionPotential": "low",
    "description": "Vinpocetine is a synthetic derivative of vincamine used for cognitive enhancement. FDA issued a CRITICAL pregnancy warning in June 2019: 'Women who are pregnant or who could become pregnant should not take vinpocetine' due to NIH evidence of miscarriage and fetal harm at normal supplement doses.",
    "mechanism": "Phosphodiesterase inhibitor that increases cerebral blood flow. Also affects fetal development, causing pregnancy loss and developmental abnormalities in offspring.",
    "history": "Synthesized from periwinkle plant (vinca) alkaloids. Prescription drug in Europe and Japan for cerebrovascular disorders. FDA issued critical pregnancy warning June 2019 after NIH National Toxicology Program findings. Tentatively ruled ineligible for supplement status.",
    "whyBanned": "Causes miscarriages and fetal harm at NORMAL supplement doses—effects seen at blood levels achieved after a single dose. FDA explicitly warns ALL women of childbearing age to avoid. Tentatively ruled ineligible for dietary supplements.",
    "legalAlternatives": ["alpha-gpc", "lions-mane", "bacopa-monnieri"],
    "metaTitle": "Vinpocetine - CAUSES MISCARRIAGE, FDA Pregnancy Warning & Safe Alternatives",
    "metaDescription": "CRITICAL: FDA warns vinpocetine causes miscarriages and fetal harm. Women of childbearing age should NOT take it. Find safe legal cognitive enhancement alternatives.",
    "keywords": ["vinpocetine", "vinpocetine pregnancy", "vinpocetine miscarriage", "vinpocetine fda warning", "vinpocetine safe", "vinpocetine alternative", "vinpocetine dangers"],
    "createdAt": "2025-01-27T00:00:00Z",
    "updatedAt": "2025-01-27T00:00:00Z"
  },
  {
    "id": "banned-picamilon",
    "slug": "picamilon",
    "name": "Picamilon",
    "alternativeNames": ["Nicotinoyl-GABA", "Pikamilon", "N-nicotinoyl-GABA", "Nicotinoyl-gamma-aminobutyric acid"],
    "category": "nootropic",
    "legalStatus": "banned_usa",
    "legalStatusDetails": "FDA issued 5 warning letters in November 2015 determining picamilon does NOT meet the dietary ingredient definition—it is a 'unique chemical entity synthesized from dietary ingredients' that crosses the blood-brain barrier.",
    "bannedBy": ["FDA"],
    "stateRestrictions": {"US": "Not a Dietary Ingredient - Products Adulterated", "Russia": "Prescription Drug"},
    "healthRisks": [{"category": "Dosage Variability", "description": "Testing found supplements containing 2.7 to 721.5 mg per daily serving—compared to Russian prescription doses of only 50-100 mg. Extreme and dangerous variability.", "severity": "moderate", "sources": ["FDA Product Testing 2015", "Analytical Chemistry Studies"]}],
    "sideEffects": ["Hypotension", "Dizziness", "Headache", "Nausea", "Flushing", "Allergic reactions"],
    "contraindications": ["Low blood pressure", "Kidney disease", "Pregnancy", "Chronic hypotension"],
    "overdoseRisk": "low",
    "addictionPotential": "low",
    "description": "Picamilon is a synthetic niacin-GABA prodrug that crosses the blood-brain barrier intact and accumulates in the brain as a separate chemical entity. FDA ruled it is NOT a dietary ingredient because it's a 'unique chemical entity synthesized from dietary ingredients'—not the same as taking GABA and niacin separately.",
    "mechanism": "Crosses the blood-brain barrier intact, then is cleaved by brain enzymes into niacin and GABA. This provides GABA effects in the brain that are NOT achievable from oral GABA supplements (which don't cross the BBB).",
    "history": "Developed in the Soviet Union in 1969. Prescription drug in Russia for anxiety, cerebrovascular disease, and depression. FDA banned as a supplement ingredient in November 2015. Despite ruling, continued appearing in supplements through 2020.",
    "whyBanned": "Not a dietary ingredient—synthetic prodrug designed to cross the BBB. Extreme dosage variability in supplements (2.7-721.5 mg vs 50-100 mg prescription). Chemical manipulation to bypass normal GABA limitations.",
    "legalAlternatives": ["l-theanine", "magnesium-glycinate", "ashwagandha"],
    "metaTitle": "Picamilon - FDA Banned Synthetic GABA Prodrug & Legal Alternatives",
    "metaDescription": "Picamilon is a synthetic GABA prodrug banned by FDA in 2015—not a legal supplement. Learn why it's not the same as GABA and find safe legal relaxation alternatives.",
    "keywords": ["picamilon", "pikamilon", "picamilon banned", "picamilon fda", "picamilon legal", "picamilon alternative", "picamilon gaba", "nicotinoyl gaba"],
    "createdAt": "2025-01-27T00:00:00Z",
    "updatedAt": "2025-01-27T00:00:00Z"
  }
];

// Check for duplicates and add new substances
let added = 0;
for (const substance of newSubstances) {
  const exists = data.substances.some(s => s.slug === substance.slug);
  if (!exists) {
    data.substances.push(substance);
    added++;
    console.log(`Added: ${substance.name}`);
  } else {
    console.log(`Skipped (exists): ${substance.name}`);
  }
}

// Write updated data
fs.writeFileSync(dataPath, JSON.stringify(data, null, 2));

console.log(`\n✅ Done! Added ${added} new substances. Total: ${data.substances.length}`);
